Development of topical treatment for cutaneous leishmaniasis caused by Leishmania major in experimental animals (original) (raw)

Natural Therapy of Cutaneous Leishmaniasis

khalifa fatnasa

International Journal For Multidisciplinary Research, 2023

View PDFchevron_right

New World cutaneous leishmaniasis: Current challenges in diagnosis and parenteral treatment

Emma Taylor

Journal of the American Academy of Dermatology, 2011

View PDFchevron_right

Cutaneous Leishmaniasis in the Dorsal Skin of Hamsters: a Useful Model for the Screening of Antileishmanial Drugs

Ivan Dario Velez

Journal of Visualized Experiments, 2012

View PDFchevron_right

Intralesional Antimonial Drug Treatment for Leishmania braziliensis Cutaneous Leishmaniasis: The Knowns and the Unknowns

naomi aronson

Clinical Infectious Diseases

View PDFchevron_right

Miltefosine for Old World cutaneous leishmaniasis: An experimental study on Leishmania major infected mice

Shereen Mossallam

View PDFchevron_right

Methodology of Clinical Trials Aimed at Assessing Interventions for Cutaneous Leishmaniasis

Byron Arana

PLoS Neglected Tropical Diseases, 2013

View PDFchevron_right

Efficacy of Miltefosine for the Treatment of American Cutaneous Leishmaniasis

J. Liliana Lopez

American Journal of Tropical Medicine and Hygiene, 2010

View PDFchevron_right

Effects of cutaneous leishmaniasis on patients' quality of life

endalew yizengaw

Research Square (Research Square), 2024

View PDFchevron_right

Visceral Leishmaniasis: New Health Tools Are Needed

Asrat Mekuria

PLoS Medicine, 2005

View PDFchevron_right

Visceral leishmaniasis: what are the needs for diagnosis, treatment and control?

Shyam Sundar

Nature Reviews Microbiology, 2007

View PDFchevron_right

Therapeutic advances in the topical treatment of cutaneous leishmaniasis: A review

Dr. Syed Ishtiaq Anjum

PLOS Neglected Tropical Diseases, 2021

View PDFchevron_right

Safety and immunogenicity of a defined vaccine for the prevention of cutaneous leishmaniasis

Ivan Dario Velez

Vaccine, 2009

View PDFchevron_right

Progressive increasing of cutaneous leishmaniasis in Kashan district, central of Iran

Mansour Sayyah

2012

View PDFchevron_right

Treatment of cutaneous leishmaniasis with a topical antileishmanial drug (WR279396): phase 2 pilot study

Max Grogl

The American journal of …, 2002

View PDFchevron_right

Optimal control of visceral, cutaneous and post kala-azar leishmaniasis

Gul Zaman

Advances in Difference Equations, 2020

View PDFchevron_right

Assessment of Interferon- Levels and Leishmanin Skin Test Results in Persons Recovered for Leishmaniasis

Mohammad Hossein Alimohammadian

American Journal of Tropical Medicine and Hygiene, 2012

View PDFchevron_right

The Epidemiology and Ecology of Leishmaniasis

David Claborn

2017

View PDFchevron_right

Pediatric Cutaneous Leishmaniasis in an Endemic Region in India

Abhay Satoskar

The American Journal of Tropical Medicine and Hygiene, 2014

View PDFchevron_right

Diagnosis and Treatment of Leishmaniasis: Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH)

naomi aronson

American Journal of Tropical Medicine and Hygiene, 2016

View PDFchevron_right

Dressings Combined with Injection of Meglumine Antimoniate in the Treatment of Cutaneous Leishmaniasis: A Randomized Controlled Clinical Trial

pedram mehryan

PLoS ONE, 2013

View PDFchevron_right

Drug Delivery by Tattooing to Treat Cutaneous Leishmaniasis

Martin Olivier

Scientific Reports, 2014

View PDFchevron_right

Ecoepidemiology of Cutaneous Leishmaniasis Outbreak, Israel

Chen Zamir

Emerging Infectious Diseases, 2008

View PDFchevron_right

Outbreak of Cutaneous Leishmaniasis in Northern Israel

Lionel Schnur

The Journal of Infectious Diseases, 2003

View PDFchevron_right

Toward an approach for cutaneous leishmania treatment

Piotr Brzezinski

Our Dermatol Online, 2013

View PDFchevron_right

Evaluation of a New Topical Treatment for the Control of Cutaneous Leishmaniasis

Ali Khamesipour

Microorganisms

View PDFchevron_right

Post-kala-azar Dermal Leishmaniasis with Mucosal Involvement: An Unusual Case Presentation including Successful Treatment with Miltefosine

Shah Golam Nabi

Journal of Health Population and Nutrition, 2013

View PDFchevron_right

Leishmania tropica’ya Karşı Cynara scolymus Ekstrelerinin In-vitro Antileishmanial Etkinliğinin Değerlendirilmesi

husniye kayalar

Kafkas Universitesi Veteriner Fakultesi Dergisi, 2021

View PDFchevron_right

Eliminating visceral leishmaniasis in South Asia: the road ahead

Dinesh Mondal

BMJ, 2019

View PDFchevron_right

Cutaneous leishmaniasis: an epidemiological survey in Iran during 2013-2015

farhood nikouee

Journal Of Nursing And Midwifery Sciences, 2017

View PDFchevron_right

Subclinical Leishmania infection in patients with rheumatic diseases under biological drugs

Carlo Contini

Infection, 2018

View PDFchevron_right

American cutaneous leishmaniasis in a northeast Brazilian city: clinical and epidemiological features

Marcos Antonio Pereira de Lima

Revista da Sociedade Brasileira de Medicina Tropical, 2018

View PDFchevron_right

Treatment of Cutaneous Leishmaniasis and Insights into Species-Specific Responses: A Narrative Review

Nadira Karunaweera

Infectious Diseases and Therapy, 2022

View PDFchevron_right

Topical treatment of Old World cutaneous leishmaniasis caused by Leishmania major: A double-blind control study

S. Halevy

Journal of the American Academy of Dermatology, 1992

View PDFchevron_right

A case report of an imported cutaneous leishmaniasis in Côte d???Ivoire

IBRAHIMA KONE

African Journal of Parasitology Research, 2021

View PDFchevron_right

Consultative meeting to develop a strategy for treatment of cutaneous leishmaniasis. Institute Pasteur, Paris. 13–15 June, 2006

F. Modabber

Kinetoplastid Biology and Disease, 2007

View PDFchevron_right